Fab Four: Biotech Stocks in 2012

1:44 PM ET Wed, 21 Dec 2011

The biotech sector has surged more than 9% in 2011, so what should investors expect for the new year? Chris Raymond, Robert W. Baird senior biotech analyst, and Karen Anderson, Morningstar senior equity analyst share insight into the sector.